Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity. [electronic resource]
- BJU international Jul 2008
- 7-10 p. digital
Publication Type: Journal Article; Review
1464-410X
10.1111/j.1464-410X.2008.07827.x doi
Administration, Intravesical Botulinum Toxins, Type A--adverse effects Female Humans Male Neuromuscular Agents--adverse effects Treatment Outcome Urinary Bladder, Overactive--complications Urinary Incontinence--complications